Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion

Drug and Alcohol Dependence

Volumn 114, Issue 1, 2011, Pages 68-72

  Mazure, Carolyn M ^a,b   Toll, Benjamin ^a,c   McKee, Sherry A ^a   Wu, Ran ^a   O'Malley, Stephanie S ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE CANCER CENTER   (United States)

Author keywords

Bupropion; Gender; Menstrual cycle phase; Smoking cessation

Indexed keywords

AMFEBUTAMONE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HELP SEEKING BEHAVIOR; HUMAN; INTERVENTION STUDY; LUTEAL PHASE; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; SMOKING; SMOKING CESSATION; SUSTAINED RELEASE FORMULATION; TOBACCO DEPENDENCE;

ADULT; BUPROPION; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79751538348     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.07.024     Document Type: Article

References (51)

1. Allen S.S., Allen A.M., Pomerleau C.S. Influence of phase-related variability in premenstrual symptomatology, mood, smoking withdrawal, and smoking behavior during ad libitum smoking, on smoking cessation outcome. Addict. Behav. 2009, 34:107-111.
2. Allen S.S., Bade T., Center B., Finstad D., Hatsukami D. Menstrual phase effects on smoking relapse. Addiction 2008, 103:809-821.
3. Allen S.S., Hatsukami D., Christianson D., Nelson D. Withdrawal and premenstrual symptomatology during the menstrual cycle in short-term smoking abstinence: effects of menstrual cycle on smoking abstinence. Nicotine Tob. Res. 1999, 1:129-142.
4. Allen S.S., Hatsukami D., Christianson D., Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine Tob. Res. 2000, 2:231-241.
5. Babor T.F., de la Fuente J.R., Saunders J., Grant M. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Geneva 1992, World Health Organization, Switzerland.
6. Benowitz N.L., Lessov-Schlaggar C.N., Swan G.E., Jacob P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin. Pharmacol. Ther. 2006, 79:480-488.
7. Bjornson W., Rand C., Connett J.E., Lindgren P., Hides M., Pope F., et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am. J. Public Health 1995, 85:223-230.
8. Bohadana A., Nilsson F., Rasmussen T., Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior. Nicotine Tob. Res. 2003, 5:111-116.
9. Brown R.A., Burgess S.A., Sales S.D., Whiteley J.A., Evans D.M., Miller I.W. Reliability and validity of a smoking Timeline Followback interview. Psychol. Addict. Behav. 1998, 12:101-112.
10. Carpenter M.J., Saladin M.E., Leinbach A.S., Larowe S.D., Upadhyaya H.P. Menstrual phase effects on smoking cessation: a pilot feasibility study. J. Womens Health 2008, 17:293-301.
11. Carpenter M.J., Upadhyaya H.P., LaRowe S.D., Saladin M.E., Brady K.T. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob. Res. 2006, 8:627-638.
12. Cole L.A., Ladner D.G., Byrn F.W. The normal variabilities of the menstrual cycle. Fertil. Steril. 2009, 91:522-527.
13. Cousins M.S., Stamat H.M., de Wit H. Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacologia 2001, 157:243-253.
14. DeBon M., Klesges R.C., Klesges L.M. Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addict. Behav. 1995, 20:335-343.
15. Dreher J.C., Schmidt P.J., Kohn P., Furman D., Rubinow D., Berman K.F. Menstrual cycle phase modulates reward-related neural function in women. PNAS 2007, 104:2465-2470.
16. Franklin T.R., Allen S.S. Influence of menstrual cycle phase on smoking cessation treatment outcome: a hypothesis regarding the discordant findings in the literature. Addiction 2009, 104(11):1941-1942.
17. Franklin T.R., Ehrman R., Lynch K.G., Harper D., Sciortino N., O'Brien C.P., et al. Menstrual cycle phase at quite date predicts smoking status in an NRT treatment trial: a retrospective analysis. J. Womens Health 2008, 17:287-292.
18. Franklin T.R., Napier K., Ehrman R., Gariti P., O'Brien C.P., Childress A.R. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob. Res. 2004, 6:171-175.
19. Gariti P., Alterman A.I., Mulvaney F.D., Epperson L. The relationship between psychopathology and smoking cessation treatment response. Drug Alcohol Depend. 2000, 60:267-273.
20. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Brit. J. Addict. 1991, 86:1119-1127.
21. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 1986, 43:289-294.
22. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., et al. A comparison of sustained-release bupropion and placebo for smoking cessation. NEJM 1997, 337:1195-1202.
23. Kabat G.C., Wynder E.L. Determinants of quitting smoking. Am. J. Public Health 1987, 77:1301-1305.
24. Lerman C., Roth D., Kaufmann V., Audrain J., Hawk L., Liu A., et al. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend. 2002, 67:219-223.
25. Lerman C., Tyndale R., Patterson F., Wileyto E.P., Shields P.G., Pinto A., et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin. Pharmacol. Ther. 2006, 79:600-608.
26. Lynch W.G. Sex differences in vulnerability to drug self-administration. Exp. Clin. Psychopharmacol. 2006, 14:34-41.
27. Lynch W.J., Potenza M.N., Cosgrove K.P., Mazure C.M. Sex differences in vulnerability to stimulant use. Women & Addiction: A Comprehensive Handbook 2009, 407-418. The Guilford Press, New York/London. K. Brady, S.E. Back, S.F. Greenfield (Eds.).
28. Marks J.L., Hair C.S., Klock S.C., Ginsberg B.E., Pomerleau C.S. Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women late luteal phase dysphoric disorder. J. Subst. Abuse 1994, 6:235-243.
29. Mello N.K., Mendelson J.H., Palmieri S.L. Cigarette smoking by women: interactions with alcohol use. Psychopharmcology (Berlin) 1987, 93:8-15.
30. O'Hara P., Portser S.A., Anderson B.P. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addict. Behav. 1989, 14:595-600.
31. Perkins K. Smoking cessation in women: special considerations. CNS Drugs 2001, 15:391-411.
32. Perkins K.A., Levine M., Marcus M., D'Amico D., Miller A., Keins A., et al. Tobacco withdrawal in women and menstrual cycle phase. J. Consult. Clin. Psychol. 2000, 68:176-180.
33. Perkins K.A., Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob. Res. 2008, 10:1245-1251.
34. Piper M.E., Cook J.W., Schlam T.R., Jorenby D.E., Smith S.S., Bolt D.M., Loh W.Y. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob. Res. 2010, 12(6):647-657.
35. Pomerleau C.S., Garcia A.W., Pomerleau O.F., Cameron O.G. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology 1992, 17:627-638.
36. Pomerleau C.S., Mehringer A.M., Marks J.L., Downey K.K., Pomerleau O.F. Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder. Addict. Behav. 2000, 25:483-497.
37. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
38. Royce J.M., Corbett K., Sorensen G., Ockene J. Gender, social pressure, and smoking cessations: The Community Intervention Trial for Smoking Cessation (COMMIT) at baseline. Soc. Sci. Med. 1997, 44:359-370.
39. Scharf D., Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of bupropion SR. Addiction 2004, 99:1462-1469.
40. Schnoll R.A., Patterson F., Wileyto E.P., Tyndale R.F., Benowitz N., Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol. Biochem. Behav. 2009, 92:6-11.
41. Shiffman S., Johnston J., Khayrallah M., Elash C., Gwaltney C., Paty J., et al. The effect of bupropion on nicotine craving and withdrawal. J. Psychopharmacol. 2000, 148:33-40.
42. Snively T.A., Ahijevych K.L., Bernhard L.A., Wewers M.E. Smoking behavior, dysphoric states and the menstrual cycle: results from single smoking sessions and the natural environment. Psychoneuroendocrinology 2000, 25:677-691.
43. Sobell L.C., Sobell M.B. Timeline Follow-back: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption 1992, 207-224. The Humana Press Inc., Rockville, MD. R. Litten, J. Allen (Eds.).
44. Sobell L.C., Sobell M.B. Alcohol consumption measures. Assessing alcohol problems: a guide for clinicians and researchers 2003, 75-99. National Institute on Alcohol Abuse & Alcoholism, Bethesda, MD. second ed. J.P. Allen, V.B. Wilson (Eds.).
45. Spitzer R.L., Kroenke K., Williams J.B.W., PHQ Primary Care Study Group Self-report version of the PRIME-MD: the PHQ primary care study. JAMA 1999, 282:1737-1744.
46. Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4(2):149-159.
47. Steinberg J.L., Cherek D.R. Menstrual cycle and cigarette smoking behavior. Addict. Behav. 1989, 14:173-179.
48. Swan G.E., Jack L.M., Ward M.M. Subgroups of smokers with difference success rates after use of transdermal nicotine. Addiction 1997, 92:207-218.
49. Toll B.A., O'Malley S.S., Katulak N.A., Wu R., Dubin J., Latimer A., et al. Comparing gain- and loss-framed messages for smoking cessation with bupropion: a randomized controlled trial. Psychol. Addict. Behav. 2007, 21:534-544.
50. Ward K.D., Klesges R.C., Zbikowski S.M., Bliss R.E., Garvey A.J. Gender differences in the outcome of an unaided smoking cessation attempt. Addict. Behav. 1997, 22:521-533.
51. Wetter D., Kenford S., Smith S., Fiore M., Jorenby D., Baker T. Gender differences in smoking cessation. J. Consult. Clin. Psychol. 1999, 67:555-562.